BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 23177107)

  • 1. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma.
    Narayanan G; Hosein PJ; Arora G; Barbery KJ; Froud T; Livingstone AS; Franceschi D; Rocha Lima CM; Yrizarry J
    J Vasc Interv Radiol; 2012 Dec; 23(12):1613-21. PubMed ID: 23177107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of 200 locally advanced (stage III) pancreatic adenocarcinoma patients with irreversible electroporation: safety and efficacy.
    Martin RC; Kwon D; Chalikonda S; Sellers M; Kotz E; Scoggins C; McMasters KM; Watkins K
    Ann Surg; 2015 Sep; 262(3):486-94; discussion 492-4. PubMed ID: 26258317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irreversible electroporation therapy in the management of locally advanced pancreatic adenocarcinoma.
    Martin RC; McFarland K; Ellis S; Velanovich V
    J Am Coll Surg; 2012 Sep; 215(3):361-9. PubMed ID: 22726894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous Image-Guided Irreversible Electroporation for the Treatment of Unresectable, Locally Advanced Pancreatic Adenocarcinoma.
    Narayanan G; Hosein PJ; Beulaygue IC; Froud T; Scheffer HJ; Venkat SR; Echenique AM; Hevert EC; Livingstone AS; Rocha-Lima CM; Merchan JR; Levi JU; Yrizarry JM; Lencioni R
    J Vasc Interv Radiol; 2017 Mar; 28(3):342-348. PubMed ID: 27993507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Irreversible electroporation as treatment of locally advanced and as margin accentuation in borderline resectable pancreatic adenocarcinoma.
    Marsanic P; Mellano A; Sottile A; De Simone M
    Med Biol Eng Comput; 2017 Jul; 55(7):1123-1127. PubMed ID: 28078482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy.
    MÃ¥nsson C; Brahmstaedt R; Nilsson A; Nygren P; Karlson BM
    Eur J Surg Oncol; 2016 Sep; 42(9):1401-6. PubMed ID: 26906114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Borderline and locally advanced pancreatic adenocarcinoma margin accentuation with intraoperative irreversible electroporation.
    Kwon D; McFarland K; Velanovich V; Martin RC
    Surgery; 2014 Oct; 156(4):910-20. PubMed ID: 25239345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility.
    Flak RV; Stender MT; Jensen TM; Andersen KL; Henriksen SD; Mortensen PB; Sall M; Thorlacius-Ussing O
    Scand J Gastroenterol; 2019 Feb; 54(2):252-258. PubMed ID: 30907286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible Electroporation for Nonthermal Tumor Ablation in Patients with Locally Advanced Pancreatic Cancer: Initial Clinical Experience in Japan.
    Sugimoto K; Moriyasu F; Tsuchiya T; Nagakawa Y; Hosokawa Y; Saito K; Tsuchida A; Itoi T
    Intern Med; 2018 Nov; 57(22):3225-3231. PubMed ID: 29984761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ablation of Locally Advanced Pancreatic Cancer with Percutaneous Irreversible Electroporation: Results of the Phase I/II PANFIRE Study.
    Scheffer HJ; Vroomen LG; de Jong MC; Melenhorst MC; Zonderhuis BM; Daams F; Vogel JA; Besselink MG; van Kuijk C; Witvliet J; de van der Schueren MA; de Gruijl TD; Stam AG; van den Tol PM; van Delft F; Kazemier G; Meijerink MR
    Radiology; 2017 Feb; 282(2):585-597. PubMed ID: 27604035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Irreversible electroporation in locally advanced pancreatic cancer: potential improved overall survival.
    Martin RC; McFarland K; Ellis S; Velanovich V
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S443-9. PubMed ID: 23128941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and feasibility of Irreversible Electroporation (IRE) in patients with locally advanced pancreatic cancer: results of a prospective study.
    Paiella S; Butturini G; Frigerio I; Salvia R; Armatura G; Bacchion M; Fontana M; D'Onofrio M; Martone E; Bassi C
    Dig Surg; 2015; 32(2):90-7. PubMed ID: 25765775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of local ablative techniques (Radiofrequency ablation and Irreversible Electroporation) in the treatment of pancreatic cancer.
    Paiella S; Salvia R; Girelli R; Frigerio I; Giardino A; D'Onofrio M; De Marchi G; Bassi C
    Updates Surg; 2016 Sep; 68(3):307-311. PubMed ID: 27535401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous Irreversible Electroporation in Locally Advanced and Recurrent Pancreatic Cancer (PANFIRE-2): A Multicenter, Prospective, Single-Arm, Phase II Study.
    Ruarus AH; Vroomen LGPH; Geboers B; van Veldhuisen E; Puijk RS; Nieuwenhuizen S; Besselink MG; Zonderhuis BM; Kazemier G; de Gruijl TD; van Lienden KP; de Vries JJJ; Scheffer HJ; Meijerink MR
    Radiology; 2020 Jan; 294(1):212-220. PubMed ID: 31687922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review of Surgical and Percutaneous Irreversible Electroporation in the Treatment of Locally Advanced Pancreatic Cancer.
    Moris D; Machairas N; Tsilimigras DI; Prodromidou A; Ejaz A; Weiss M; Hasemaki N; Felekouras E; Pawlik TM
    Ann Surg Oncol; 2019 Jun; 26(6):1657-1668. PubMed ID: 30843163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of resistance as a measure of successful tumor ablation during irreversible electroporation of the pancreas.
    Dunki-Jacobs EM; Philips P; Martin RC
    J Am Coll Surg; 2014 Feb; 218(2):179-87. PubMed ID: 24315888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous irreversible electroporation of locally advanced pancreatic carcinoma using the dorsal approach: a case report.
    Scheffer HJ; Melenhorst MC; Vogel JA; van Tilborg AA; Nielsen K; Kazemier G; Meijerink MR
    Cardiovasc Intervent Radiol; 2015 Jun; 38(3):760-5. PubMed ID: 25288173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacy.
    Ansari D; Kristoffersson S; Andersson R; Bergenfeldt M
    Scand J Gastroenterol; 2017 Nov; 52(11):1165-1171. PubMed ID: 28687047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
    Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
    J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irreversible electroporation of pancreatic adenocarcinoma: a primer for the radiologist.
    Rashid MF; Hecht EM; Steinman JA; Kluger MD
    Abdom Radiol (NY); 2018 Feb; 43(2):457-466. PubMed ID: 29051982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.